Generic Name : Linagliptin and Metformin Hydrochloride Pronunciation : LIN-a-GLIP-tin- met-FOR-min Therapeutic Classification : Antidiabetics ICD Code : Y42.3
International- Jentadueto. Why it is prescribed (Indications) :
This combination medication contains dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide, prescribed for type 2 diabetes in certain patients along with diet and exercise. When it is not to be taken (Contraindications):
Contraindicated in patients with type 1 diabetes, stroke, recent heart attack, shock, severe infection, low blood oxygen levels, kidney or liver problems, and hypersensitivity.
Dosage & When it is to be taken :
Dose is based on patientís condition. The recommended dose is 2.5 mg linagliptin/1000 mg metformin hydrochloride twice daily. How it should be taken :
It comes as a tablet to take by mouth, with meals as directed by your doctor. Warnings and Precautions :
* Caution should be exercised in patients with history of heart disease, lung or breathing problems, thyroid problems, stomach problems, adrenal or pituitary problems, lactic acidosis, inflammation of the pancreas, gallstones, high blood cholesterol, alcohol abuse, angioedema, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
* Avoid alcohol consumption.
* Monitor kidney function, fasting blood glucose, hemoglobin A1c, and complete blood cell counts regularly while taking this medication. Side Effects :
Cough, decreased appetite, diarrhea, gas, headache, indigestion, nausea, runny or stuffy nose, sore throat, stomach upset, vomiting, and weakness.
* Avoid excess dosage. Storage Conditions :
Store it at room temperature.
Comment & Contribute
Ask an Expert